These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23939305)

  • 21. Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study.
    Espay AJ; Beaton DE; Morgante F; Gunraj CA; Lang AE; Chen R
    Mov Disord; 2009 May; 24(7):1001-8. PubMed ID: 19230031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
    van Hilten JJ; van der Zwan AD; Zwinderman AH; Roos RA
    Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spiral drawing time as a measure of bradykinesia.
    Banaszkiewicz K; Rudzińska M; Bukowczan S; Izworski A; Szczudlik A
    Neurol Neurochir Pol; 2009; 43(1):16-21. PubMed ID: 19353440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between the grooved pegboard test and clinical motor symptom evaluation across the spectrum of Parkinson's disease severity.
    Sage MD; Bryden PJ; Roy EA; Almeida QJ
    J Parkinsons Dis; 2012; 2(3):207-13. PubMed ID: 23938228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.
    Ramaker C; Marinus J; Stiggelbout AM; Van Hilten BJ
    Mov Disord; 2002 Sep; 17(5):867-76. PubMed ID: 12360535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
    Martínez-Martín P; Gil-Nagel A; Gracia LM; Gómez JB; Martínez-Sarriés J; Bermejo F
    Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision.
    Martinez-Martin P; Forjaz MJ
    Mov Disord; 2006 Aug; 21(8):1182-8. PubMed ID: 16673397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
    Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?
    Martínez-Martín P; Benito-León J; Alonso F; Catalán MJ; Pondal M; Tobías A; Zamarbide I
    Mov Disord; 2003 Sep; 18(9):985-92. PubMed ID: 14502665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
    Goetz CG; Stebbins GT; Chmura TA; Fahn S; Poewe W; Tanner CM
    Mov Disord; 2010 Jul; 25(9):1190-4. PubMed ID: 20629138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
    Louis ED; Lynch T; Marder K; Fahn S
    Mov Disord; 1996 Mar; 11(2):185-92. PubMed ID: 8684390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.
    Goetz CG; Stebbins GT; Wolff D; DeLeeuw W; Bronte-Stewart H; Elble R; Hallett M; Nutt J; Ramig L; Sanger T; Wu AD; Kraus PH; Blasucci LM; Shamim EA; Sethi KD; Spielman J; Kubota K; Grove AS; Dishman E; Taylor CB
    Mov Disord; 2009 Mar; 24(4):551-6. PubMed ID: 19086085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting outcomes in Parkinson's disease: comparison of simple motor performance measures and The Unified Parkinson's Disease Rating Scale-III.
    Grill S; Weuve J; Weisskopf MG
    J Parkinsons Dis; 2011; 1(3):287-98. PubMed ID: 23939309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
    Song J; Fisher BE; Petzinger G; Wu A; Gordon J; Salem GJ
    Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ambulatory persistence power curve: motor planning affects ambulatory persistence in Parkinson's disease.
    Xanthopoulos P; Heilman KM; Drago V; Pardalos P; Foster PS; Skidmore FM
    Neurosci Lett; 2008 Dec; 448(1):105-9. PubMed ID: 18940232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the ADL part of the unified Parkinson's disease rating scale measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation.
    Hariz GM; Lindberg M; Hariz MI; Bergenheim AT
    Mov Disord; 2003 Apr; 18(4):373-81. PubMed ID: 12671942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinsonian Hand or Clinician's Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts.
    Williams S; Wong D; Alty JE; Relton SD
    J Parkinsons Dis; 2023; 13(4):525-536. PubMed ID: 37092233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability and validity of a new dexterity questionnaire (DextQ-24) in Parkinson's disease.
    Vanbellingen T; Nyffeler T; Nef T; Kwakkel G; Bohlhalter S; van Wegen EE
    Parkinsonism Relat Disord; 2016 Dec; 33():78-83. PubMed ID: 27663063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.